Precision Immunology Platform

About ALLInBio

ALLInBio is a private, preclinical-stage biotech founded in 2020 and based in San Francisco. The company is pioneering a precision-medicine strategy for chronic inflammatory and immunological (I&I) diseases, moving away from the current trial-and-error standard of care. By leveraging genetics and likely AI/ML tools, it seeks to identify patients at high risk for severe disease progression and intervene therapeutically before advanced clinical manifestation. This approach targets a significant unmet need where many patients fail to achieve remission with existing treatments.

Therapeutic Areas